EDGAR Filing Documents for 0001171843-22-004456

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001171843-22-004456

Filing Date

2022-06-22

Accepted

2022-06-22 08:00:33

Documents

Period of Report

2022-06-22

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	mdna20220617_6k.htm	6-K	15972
2	EXHIBIT 99.1	ex_388200.htm	EX-99.1	733742
3	EXHIBIT 99.2	ex_388202.htm	EX-99.2	648365
4	EXHIBIT 99.3	ex_388203.htm	EX-99.3	394264
5		davidson.jpg	GRAPHIC	5562
6		endocytosis.jpg	GRAPHIC	18285
7		il2receptor.jpg	GRAPHIC	15099
8		logo.jpg	GRAPHIC	3268
9		mdna.jpg	GRAPHIC	26005
10		nexia.jpg	GRAPHIC	5403
11		org.jpg	GRAPHIC	15092
12		phase.jpg	GRAPHIC	32754
13		product.jpg	GRAPHIC	24223
14		pwc.jpg	GRAPHIC	2425
15		pwc_foot.jpg	GRAPHIC	8080
16		receptor.jpg	GRAPHIC	15654
17		superkines.jpg	GRAPHIC	29198
18		targeting.jpg	GRAPHIC	7839
	Complete submission text file	0001171843-22-004456.txt		2082577

Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2

Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555

Medicenna Therapeutics Corp. (Filer) CIK: 0001807983 (see all company filings)